Actively Recruiting
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
Led by City of Hope Medical Center · Updated on 2026-02-20
700
Participants Needed
11
Research Sites
239 weeks
Total Duration
On this page
Sponsors
C
City of Hope Medical Center
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study assesses the impact of cannabis (also commonly called marijuana, weed, or THC) use on quality of life among patients with multiple myeloma who are receiving chemotherapy. It also evaluates the potential benefits and harms of cannabis use.
CONDITIONS
Official Title
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Documented informed consent of the participant
- Age 18 years or older
- ECOG performance status of 3 or less
- Ability to read and understand English
- Newly diagnosed with histologically confirmed multiple myeloma
- May have started first line therapies and received up to four cycles
- Healthcare provider participants must be licensed physicians, physician assistants, nurse practitioners, or registered nurses
- Healthcare providers must currently practice in oncology or provide direct care to oncology patients
- Healthcare providers must be affiliated with City of Hope
- Healthcare providers must be able to read and understand English
- Healthcare providers must provide documented informed consent
You will not qualify if you...
- Patients must not have completed five cycles of first line therapy or undergone any second line therapy
- Patients with other active malignancies
- Patients who have undergone autologous hematopoietic stem cell transplantation
- Patients unable to comply with study assessments
- Healthcare providers reporting directly to the study principal investigator (Dr. Richard Lee)
- Healthcare providers who are members of the study team or involved in survey design or analysis
- Healthcare providers with a real or perceived conflict of interest that could bias survey responses
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 11 locations
1
CTCA at Western Regional Medical Center
Goodyear, Arizona, United States, 85338
Not Yet Recruiting
2
City of Hope Medical Center
Duarte, California, United States, 91010
Actively Recruiting
3
City of Hope Seacliff
Huntington Beach, California, United States, 92648
Not Yet Recruiting
4
City of Hope at Irvine Lennar
Irvine, California, United States, 92618
Actively Recruiting
5
City of Hope at Long Beach Elm
Long Beach, California, United States, 90813
Not Yet Recruiting
6
City of Hope at Newport Beach Fashion Island
Newport Beach, California, United States, 92660
Not Yet Recruiting
7
City of Hope South Pasadena
South Pasadena, California, United States, 91030
Not Yet Recruiting
8
City of Hope Upland
Upland, California, United States, 91786
Not Yet Recruiting
9
City of Hope West Covina
West Covina, California, United States, 91790
Not Yet Recruiting
10
City of Hope Atlanta Cancer Center
Newnan, Georgia, United States, 30265
Not Yet Recruiting
11
City of Hope at Chicago
Zion, Illinois, United States, 60099
Not Yet Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here